Bellus Health (BLU.TO) Buy, Sell or Hold

Bellus Health (BLU.TO)

19.32

-0.18 (0.92%)

as of Jun 29, 2023, 2:11:38 pm Market Open.

10 watching

RISKY

The outlook is still quite good. People who use their competing chronic cough treatment lose their sense of taste. They are applying now for their drug's use for other conditions.

RISKY

A pharma company working on a new drug for chronic cough. Early testing has produced good effectiveness and no nasty side effects. Tests should be completed within the year. He believes 60 to 300 patients are being tested. They have great potential. A speculative buy. It may become a takeover target.

Showing 1 to 2 of 2 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Bellus Health (BLU.TO) Frequently Asked Questions

What is Bellus Health stock symbol?

Bellus Health is a Canadian stock, trading under the symbol BLU.TO (previously BLU-T on Stockchase) on the Toronto Stock Exchange (BLU-CT). It is usually referred to as TSX:BLU or BLU.TO

Is Bellus Health a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on BLU.TO (previously BLU-T on Stockchase) on Stockchase. Read the latest expert commentary for Bellus Health.

Is Bellus Health a good investment or a top pick?

Bellus Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Bellus Health.

Why is Bellus Health stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Bellus Health.

Is Bellus Health worth watching?

Bellus Health is followed by 10 investors on Stockchase and is a trending stock that is worth watching.

What is Bellus Health stock price?

On 2023-06-29, Bellus Health (BLU.TO) stock closed at a price of $19.32.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Bellus Health (BLU.TO)